The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 8,652 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 10,117 | 372,753 | SH | SOLE | 372,753 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 1,893 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 7,275 | 698,825 | SH | SOLE | 698,825 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 1,052 | 974,318 | SH | SOLE | 974,318 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 722 | 145,300 | SH | SOLE | 145,300 | 0 | 0 | ||
| ARDELYX INC | COM | 039697107 | 382 | 26,891 | SH | SOLE | 26,891 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 11,644 | 575,309 | SH | SOLE | 575,309 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 11,866 | 976,599 | SH | SOLE | 976,599 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 122 | 10,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 2,100 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 627 | 99,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 950 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| CAS MED SYS INC | COM PAR $0.004 | 124769209 | 6,730 | 4,179,838 | SH | SOLE | 4,179,838 | 0 | 0 | ||
| CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 7,826 | 1,150,925 | SH | SOLE | 1,150,925 | 0 | 0 | ||
| CLEARSIDE BIOMEDICAL INC | COM | 185063104 | 1,565 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 3,228 | 91,898 | SH | SOLE | 91,898 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 2,684 | 88,500 | SH | SOLE | 88,500 | 0 | 0 | ||
| EDGE THERAPEUTICS INC | COM | 279870109 | 13,003 | 1,040,265 | SH | SOLE | 1,040,265 | 0 | 0 | ||
| ENDOLOGIX INC | NOTE 2.250%12/1 | 29266SAA4 | 86 | 96,000 | PRN | SOLE | 0 | 0 | 96,000 | ||
| ESSA PHARMA INC | COM | 29668H104 | 1,330 | 605,300 | SH | SOLE | 605,300 | 0 | 0 | ||
| EXELIXIS INC | COM | 30161Q104 | 1,193 | 80,000 | SH | Put | SOLE | 80,000 | 0 | 0 | |
| GW PHARMACEUTICALS PLC | ADS | 36197T103 | 4,470 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 17,249 | 4,700,000 | SH | SOLE | 4,700,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | NOTE 4.750% 2/1 | 452907AK4 | 10,395 | 10,500,000 | PRN | SOLE | 0 | 0 | 10,500,000 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 367 | 100,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| IRIDEX CORP | COM | 462684101 | 21,851 | 1,554,146 | SH | SOLE | 1,554,146 | 0 | 0 | ||
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | 9,440 | 70,000 | SH | Put | SOLE | 70,000 | 0 | 0 | |
| LION BIOTECHNOLOGIES INC | COM | 53619R102 | 26,479 | 3,809,944 | SH | SOLE | 3,809,944 | 0 | 0 | ||
| LION BIOTECHNOLOGIES INC | COM | 53619R102 | 1,043 | 150,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| MANNKIND CORP | COM | 56400P201 | 58 | 90,000 | SH | Put | SOLE | 90,000 | 0 | 0 | |
| MARVELL TECHNOLOGY GROUP LTD | ORD | G5876H105 | 6,935 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 4,210 | 706,383 | SH | SOLE | 706,383 | 0 | 0 | ||
| NEURODERM LTD | ORD SHS | M74231107 | 14,784 | 665,944 | SH | SOLE | 665,944 | 0 | 0 | ||
| OHR PHARMACEUTICAL INC | COM NEW | 67778H200 | 15 | 10,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| ONCOBIOLOGICS INC | *W EXP 02/18/201 | 68235M113 | 18 | 96,833 | SH | SOLE | 96,833 | 0 | 0 | ||
| ONCOBIOLOGICS INC | *W EXP 05/18/201 | 68235M121 | 76 | 96,833 | SH | SOLE | 96,833 | 0 | 0 | ||
| ONCOBIOLOGICS INC | COM | 68235M105 | 88 | 29,082 | SH | SOLE | 29,082 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 7,039 | 470,834 | SH | SOLE | 470,834 | 0 | 0 | ||
| PLURISTEM THERAPEUTICS INC | COM | 72940R102 | 30 | 21,100 | SH | Put | SOLE | 21,100 | 0 | 0 | |
| RA PHARMACEUTICALS INC | COM | 74933V108 | 5,740 | 377,909 | SH | SOLE | 377,909 | 0 | 0 | ||
| RECRO PHARMA INC | COM | 75629F109 | 2,418 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ROCKWELL MED INC | COM | 774374102 | 917 | 140,000 | SH | Put | SOLE | 140,000 | 0 | 0 | |
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 1,372 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
| SPECTRANETICS CORP | COM | 84760C107 | 674 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 2,593 | 162,600 | SH | SOLE | 162,600 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 27,192 | 3,513,161 | SH | SOLE | 3,513,161 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 2,903 | 375,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| WEBMD HEALTH CORP | COM | 94770V102 | 3,966 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 1,548 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||